A Look At Evolv Technologies Holdings (EVLV) Valuation After Guidance Hike And Strong First Quarter Results

Evolv Technologies

Evolv Technologies

EVLV

0.00

Earnings driven move after guidance hike

Evolv Technologies Holdings (EVLV) recently reported first quarter 2026 results, lifting full year revenue guidance and outlining an expectation for positive adjusted EBITDA, a combination that appears central to the latest stock reaction.

The Q1 guidance hike and customer wins appear to sit against mixed momentum, with the share price up 23.56% over 90 days but down 6.87% year to date. The 1 year total shareholder return of 9.28% points to more muted long run progress.

If this kind of earnings driven move has caught your eye, now may be a time to scan the market for other AI focused security and automation plays using our 46 AI infrastructure stocks

With the stock up over the past year but still trading at a value score of 2 and with ongoing class action settlement costs, is Evolv a misunderstood AI security player at a discount, or is the market already pricing in future growth?

Most Popular Narrative: 38% Undervalued

Analysts’ most followed narrative suggests a fair value of $10.00 per share versus the last close at $6.24, putting Evolv firmly in “valuation debate” territory.

The increasing prevalence of large multi-year contracts with public school systems and hospitals, driven by heightened public safety concerns in high-density environments, is expanding Evolv's total addressable market and should support outsized revenue growth over the coming years.

Growing customer adoption and frequent upgrades to newer platforms like Gen2 and eXpedite reflect a successful technology road map that is boosting customer retention rates and fostering longer-term subscription commitments, positively impacting both ARR and net margins.

Analysts are baking in brisk revenue expansion, firmer margins and a rich future earnings multiple to reach that $10.00 mark. Curious which specific growth assumptions and share count changes sit underneath that outcome, and how they connect to the latest guidance hike.

Result: Fair Value of $10.00 (UNDERVALUED)

However, shifts to direct hardware sales that pressure margins, and any renewed legal or regulatory issues, could quickly challenge the upbeat growth narrative you have just seen.

Another View: Rich Sales Multiple Signals Caution

That $10.00 fair value hinges on aggressive earnings assumptions, but the current P/S of about 7x tells a different story. EVLV trades well above the US Electronic industry average of 2.9x and the fair ratio of 3.6x, even though it sits slightly below peer levels at 8.4x. For you, that gap means the market is already asking you to pay a premium price for each dollar of sales, which cuts the margin for error if growth or profitability fall short.

NasdaqCM:EVLV P/S Ratio as at May 2026
NasdaqCM:EVLV P/S Ratio as at May 2026

Next Steps

With sentiment clearly split between potential future upside and real concerns, it may be useful to act promptly and stress test the full picture yourself using 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Evolv has you thinking harder about risk, growth and valuation, do not stop here. Broaden your watchlist now so you are not late to the next opportunity.

  • Target potential mispricings by scanning 48 high quality undervalued stocks that combine solid cash flows with balance sheets many investors are still ignoring.
  • Strengthen the defensive side of your portfolio by reviewing solid balance sheet and fundamentals stocks screener (46 results) that aim to weather tougher conditions without constant refinancing worries.
  • Get ahead of the crowd by filtering screener containing 21 high quality undiscovered gems that pair robust fundamentals with lower visibility, before attention and liquidity catch up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.